Related references
Note: Only part of the references are listed.Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
V. Smith et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Rituximab: a potential therapeutic advance in scleroderma What is the evidence?
Robert W. Simms et al.
RHEUMATOLOGY (2010)
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Dimitrios Daoussis et al.
RHEUMATOLOGY (2010)
B Cell Depletion With Rituximab in Patients With Diffuse Cutaneous Systemic Sclerosis
Robert Lafyatis et al.
ARTHRITIS AND RHEUMATISM (2009)
Share Paper
